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Abstract
Obtaining consent for HIV research is complex, particularly in low- and middle-income countries. Low levels of education,
complexity of science and research processes, confusion about basic elements of research, and socio-economic conditions
that make access to medical care difficult have collectively led to concerns about the adequacy of the consent process.
Given the exponential growth of HIV prevention and treatment research in South Africa, HIV researchers are increasingly
facing challenges obtaining authentic informed consent from potential participants. It is anticipated that HIV cure research,
despite being in its infancy in South Africa, will introduce a new discourse into a population that is often struggling to
understand the differences between ‘cure’, ‘preventive and therapeutic vaccines’ and other elements of the research process.
Coupled with this, South Africa has a complex history of ‘illegitimate’ or ‘false cures’ for HIV. It is therefore logical to
anticipate that HIV cure research may face significant challenges during consent processes.
HIV prevention research in South Africa has demonstrated the importance of early community engagement in educating
potential research participants and promoting community acceptance of research. Consequently, in an attempt to extrapolate
from this experience of engaging with communities early regarding cure research, a 15-minute educational video entitled
‘I have a dream: a world without HIV’ was developed to educate and ultimately empower potential research participants
to make informed choices during consent processes in future HIV cure clinical trials. To aid others in the development of
educational interventions, this paper discusses the challenges faced in developing this educational video.
Keywords: HIV cure, informed consent, community engagement, ethics
Background
Obtaining informed consent is essential for the ethical conduct
of research. Yet problems persist in its implementation amid
concerns that participant consent is not truly informed. Empirical
research has raised concerns about the therapeutic misconception
(the mistaken belief that a clinical trial will be of clinical benefit
to participants with little or no risk), failure of participants to
understand key concepts, as well as questions about whether
consent is truly voluntary [1–4]. These issues are even more acute
in low- and middle-income countries (LMIC), where low levels of
formal education and language, and power disparities between
researcher and participant, often additionally challenge the ability
of potential participants to sufficiently understand and make an
informed choice. Socio-economic conditions make accessing
medical care problematic. Medical care is often provided as part
of participation in a trial, and this can conflate the distinction
between care and medical research, exacerbating the therapeutic
misconception. Communicable and non-communicable diseases
affecting LMICs are in need of research to improve health, but
the complex social conditions make informed consent challenging.
Such challenging social conditions have been prevalent in HIV
research where low levels of literacy or education amongst research
participants and power differentials between staff and participants
have tested the consent process [5].
HIV cure research will bring added complexity to Africa where there
is a history of false cures, such as holy water, prayer or herbal
products, and the scientific and lay understanding of cure may
differ. Large-scale vaccine trials have recently started in South
Africa, but there is evidence to suggest that a vaccine will be
perceived as ‘cure medicine’ [6]. Current preventive vaccine trials
may be conflated with future therapeutic vaccine trials and
assessing understanding will be essential.
Preliminary interviews with stakeholders in the Western Cape
province of South Africa revealed limited awareness and
understanding of cure research. Rumours of false cures in the
community were reported amid beliefs that HIV is an incurable
or ‘end time illness’ [7]. The science of cure research will indeed
be complex and low levels of literacy amongst the likely target
population, coupled with the diversity of languages spoken in
South Africa, will make informed consent challenging. Research
towards an HIV cure in South Africa may also face high levels of
distrust of scientific research [8], fuelled in part by the history
of exploitation and the cultural significance of blood in some
communities [9]. It is therefore important that the cure research
narrative is set early. This will help resolve any misconceptions and
prepare potential research participants for the forthcoming research
and empower them to make informed decisions.
As a result of lessons learned from HIV research, there has been
recognition of the importance of community engagement, the
manner of communication of information in research and its
understanding. Prevention research demonstrated the importance
of early and sustained community engagement in ensuring
scientific rigour, good ethical conduct in research, as well as
community acceptance [10]. The development of special media
such as video, flip charts, booklets and role plays have been
recommended to help inform study participants [11]. The use of
a video in informed consent has had some success in increasing
knowledge and participation [12], and visual aids have been used
as part of the consent process in HIV research [13]. As part of
the Carraguard study that had three sites in South Africa,
participants watched a 25-minute video in their local language
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and received an illustrated booklet outlining study procedures [8].
Although the Carraguard video was not tested to assess its impact
on understanding, other studies in South Africa have demonstrated
the usefulness of videos in HIV treatment: a 17-minute video has
been shown to improve understanding of treatment and adherence
and there are indications that the development of a culturally
sensitive video can improve the understanding around taking
antiretroviral therapy (ART) [14,15].
To address some of the misconceptions and begin a discussion
on cure research, we sought to create a package of educational
tools to prepare potential participants for cure research. This
included a video, pamphlets and an interactive online platform
currently under development. The first of these was a 15-minute
video that introduces cure research, addresses misconceptions,
introduces basic understanding of the research process, and
reinforces treatment and prevention. From conceptualisation to
completion, the process took one year. The video ‘I have a dream:
a world without HIV’ is publically available on YouTube (https://
www.youtube.com/watch?v=oNfw9n5nBtU). To aid others in the
development of similar educational tools, this paper reflects on
some of the ethical challenges in developing such a video.
Conceptualising cure and managing expectations
At this early stage of cure research, the need to manage
expectations is paramount. The research is primarily focused on
proof-of-concept studies with no large-scale trials planned as yet.
The video had to navigate a complex interplay of aims: inform
about forthcoming cure research and give some hope to people
living with HIV (PLHIV), while also managing expectations and
reinforcing the importance of treatment and prevention.
Conceptualising cure has proven to be challenging, in part due
to the different strategies under investigation. Currently, studies
working towards a cure are either focused on a sterilising cure
or long-term remission [16]. Although both fall under the umbrella
of ‘cure research’ they result in clinically different outcomes.
Caution has been urged about the use of the word ‘cure’ or ‘cure
research’ as potentially creating false and confusing, if not
misleading, expectations [17,18]. There has also been the
suggestion that this type of research should not be described as
research, but rather as an ‘experiment’. This more accurately reflects
the preliminary stage of the research and can be used to manage
expectations, because there is unlikely to be any medical benefit
to participants at this early stage [19,20]. Other advocated
cure-related terms include ‘sustained viral remission’ [21], ‘HIV
remission’ [22] and ‘curative intervention’ [16].
Adding complexity to this problem is the knowledge that the
biomedical understanding of a cure differs from the lay
understanding, particularly in a traditional African context where
disease is often seen as a natural occurrence and treatment
perceived as a way to coax the disease to leave the patient alone
[23]. The community understanding of cure may therefore not
be congruent with the scientific understanding of cure. There may
be difficulty in distinguishing between sterilising cure, functional
cure and remission because, in many traditional African
communities with concepts of disease and cure, remission or
absence of symptoms is regarded as cure [24]. In the South African
context, ‘cures’ that may be available in the community may be
in the form of herbal remedies or spiritual healing [8]. Early in
script development, we were aware of the differing layers of cure:
the biomedical understanding of cure, the traditional African
understanding of cure in which it is understood as an absence
of disease, and the lay and ‘quack’ cures which are often false
claims such as holy water. Undoubtedly, in these early-phase trials,
the research is unlikely to be described as ‘cure’ in the informed
consent documents, as to do so would risk misleading the
participants. However, our video is not tied to any particular clinical
trial, but rather describes the burgeoning area of cure research
and a word that suited this body of work was necessary. A ‘cure’
within the traditional African context may be more closely aligned
with remission: the patient may look and feel ‘cured’ but the HIV
may return. Indeed, suppression of the virus using ART could also
fall within this understanding of a cure, adding further complexity.
In light of South Africa‘s complex history of false cures and the
traditional African understanding of cure, we felt ethically obliged
to provide scientifically sound information that was nevertheless
culturally sensitive. As the first educational intervention on cure
research in South Africa, our video would likely frame discussions
with the community on cure research. We were faced with two
options: we could either wait until the science developed and the
concepts that would be used became clearer until producing a
video based on empirical investigations of these terms, or develop
an educational intervention with input from various stakeholders
and community members that would be empirically tested and
made widely available to HIV clinics throughout South Africa.
However, the former would have represented a missed opportunity
to begin early engagement on this complex matter, and HIV
research has demonstrated the importance of early and sustained
engagement.
Decisions about concepts thus became paramount. ‘Remission’
was mooted as an alternative to ‘cure’ and perhaps more accurately
reflects the possibility of a return of the disease; however, the
word cure has already been introduced in the discourse. Ultimately,
after drawing on the experiences of the clinicians in our team,
as well as considerable consultation with medical doctors, scientists,
nurses, HIV counsellors and PLHIV, it was decided to use both
cure and remission. We were mindful that the purpose of the video
was not to form part of an informed consent process but rather
to introduce new concepts into the HIV research discourse; to start
the conversations amongst community members so that they felt
empowered to seek more information and have informed
discussions during any future informed consent processes.
Although the conceptualisation of cure may differ, cure is firmly
embedded within the current HIV discourse. The International AIDS
Society has described its cure programme as ‘Towards an HIV cure’
and this is likely to be taken up by the media. Perhaps by
discussing cure we have begun to cement it in the South African
discourse. There is, however, a need to distinguish a scientific cure
from other forms of purported cures. By confronting the issue,
we sought to educate and inform so that there is limited confusion
on future possible cures vis-a-vis false cures.
Cure is not defined in this video, but the Berlin patient is described
as being cured. In contradistinction, the period during which the
Mississippi Baby appeared to be free of HIV while not on treatment
is framed as remission and described in the context of cancer
treatment whereby patients may look and feel well, but the cancer
may return. Admittedly, this leaves the viewer free to ascribe their
own understanding to these terms. In a short 15-minute video
it was difficult to expand on these differences, but future
educational interventions might want to focus specifically on these.
Potential ethical implications and consequences
of the video content
Despite the decision to use the word ‘cure’, the title of the video
does not mention cure, but rather focuses on the ideal of an
HIV-free world. Throughout the video, it is reinforced that no cure
is currently available. We also sought to remind the audience that
cure research is in a very early phase, experimental and with no
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guarantee of success. Concerns about content were not limited
to use of the word ‘cure’ but soon turned to possible inadvertent
consequences of the inclusion and exclusion of specific issues.
Topics were selected for discussion in the video after considerable
consultation with various HIV stakeholders.
In prevention trials, there was a confusion amongst participants
between ‘vaccine’ and ‘cure’, as well as confusion between the
experimental nature of the prevention trial and established
prevention programs [10]. Similar difficulty in distinguishing
between experimental cure research and established treatment can
be foreseen. It is essential that any progress in cure research should
not undermine success in treatment and prevention made to date.
Specifically, our concern lay with possible inadvertent consequences
arising from a discussion of treatment interruption. Therefore,
discussions about the Mississippi Baby and the cessation of
treatment required careful wording in order not to encourage such
unsupervised treatment interruption.
The design of future HIV cure trials in South Africa is uncertain,
but it is anticipated that participants might be asked to stop taking
ART at some point. Participants could risk a viral load rebound
and could even potentially develop resistance to their current
treatment regimen. The video narrative stresses the dangers of
treatment interruption, even for one day, and a clear message that
the cessation of ART must only be done in a controlled clinical
setting where HIV viral load can be closely monitored is presented.
In the video, cure is also portrayed as part of a package that
includes treatment and prevention, which together may end the
HIV epidemic. Although the video was intended to focus on cure
only, discussions with stakeholders stressed the importance of
emphasising both treatment and prevention; this discussion now
precedes discussions on cure in the video. There are some notable
omissions, such as discussions on abstinence, prevention of
mother-to-child transmission (PMTCT), and pre- and post-exposure
prophylaxis, and cursory treatment of certain issues, such as the
side effects of ART. While these key issues have dominated the
HIV conversation for the past few decades, they had to be omitted
for the sake of brevity.
The length and complexity of informed consent forms have been
continuously identified as problematic and this was kept in mind
throughout. There is a need to achieve the appropriate balance
between giving enough information so that potential participants
are able to balance the risks and benefits, with the need not to
exceed an individual‘s capacity for understanding during the
consent process [5]. We also sought to develop a clear,
understandable and short video. Our initial 30-page script entitled
‘What every South African should know about HIV and AIDS’ was
eventually reduced to a 5-page script. Supplementary materials
are necessary and, in response to this need, the team has
developed separate pamphlets on HIV prevention, treatment and
cure.
Culturally appropriate video
In order to increase authenticity, healthcare professionals working
in public health facilities were used as actors. Dr Maseke is played
by a black female Nigerian doctor, dispelling the myth that all
people of authority in South Africa are white or indeed male. There
were concerns about featuring a foreign doctor, but this scenario
reflects the reality of the public health care sector in South Africa.
Nomsa is played by an HIV adherence monitor and Andiswa is
played by a clinical trial recruiter. Prof Cotton plays himself (a
pre-eminent paediatric HIV researcher), as do Dr Riaad Moosa (a
prominent doctor and comedian), Zackie Achmat (a prominent
activist) and Archbishop Desmond Tutu (a South African icon,
Nobel Peace Prize laureate, social rights activist and active HIV
campaigner).
Since screening the video, the decision to include two women as
the HIV-positive actors, in lieu of a male and female actor, has
been questioned because it may fuel misconceptions that women
are carriers of the disease. In South Africa, women are generally
in charge of the care of a child, and thus the caregiver needed
to be female; equally, the issues that Nomsa discusses, such as
rape and female condoms, also necessitated a female actor. In
South Africa, HIV affects a disproportionate number of young black
women and this video speaks to these women. It is possible that
men may not readily identify with these characters, but this once
again underscores the fact that this video is not intended to be
the only message on HIV cure research, but the first in what is
hoped to be a series of educational interventions on cure research
targeted at different populations, using a variety of different media.
Due to the importance of traditional medicine in South Africa, it
was also decided to discuss the interplay it may have with ART.
The video also contains a short interaction between two actors
regarding consultations with traditional healthcare practitioners
(THPs). THPs are widely used in South Africa, but some traditional
medicines have been shown to interact with conventional
medication, such as ART. This has caused tension between
biomedicine and traditional medicine, but the reality is that many
PLHIV may also take traditional medicines to alleviate the side
effects of ART. We chose to recognise this interplay between
traditional medicine and biomedicine and acknowledge its cultural
significance. We attempted to do this in a manner which
emphasises the importance of discussing proposed alternative
treatments, such as herbals and other traditional medications, with
clinic staff before patients take them, rather than to dissuade
patients from consulting with THPs.
Translation and understanding
Finally, as with informed consent, the communication of the
information is just as important as the content. Since English is
widely understood in South Africa, it was chosen as the language
of communication in the video. However, it is one of 11 official
languages in South Africa, and since it is only the fifth most widely
spoken home language in the country, assumptions about
proficiency should be guarded [25]. Informed consent should
preferably be discussed and obtained in a participant‘s home
language, but indigenous languages have not all developed the
medical or scientific vocabulary to allow for translation of new
scientific terms.
Initially, professional translators added subtitles in isiXhosa,
Afrikaans and Zulu, based on the script. Translation of study
material generally benefits from the involvement of those who
have worked with the community, helping to ensure it is pitched
at the correct level and includes appropriate metaphors and
concepts [5]. Native speakers thus reviewed these drafts and, while
differences arose, most could be resolved by the clinically trained,
native Zulu and Afrikaans speaking team members. However,
having no native isiXhosa speaker on the project did result in
difficulty, in particular with translating the term ‘remission’. It was
eventually decided to use the same term used by study nurses,
but it is likely that others may adopt different terms. Consulting
with African language centres in the future may address some of
these issues, but differences in translation are likely to be
unavoidable.
Moving forward
Cure research is an extremely exciting development for PLHIV in
South Africa, but discussions to date have largely remained within
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the domain of the academic environment. This conversation must
start to engage the community, both to familiarise potential
participants with cure research and also to involve them in
developing cure strategies and trials. To achieve this, potential
research participants should be comfortable with ‘cure speak’ and
we have a responsibility to make the science accessible to them.
Engagement in early-phase cure research is complex because the
science is novel and, in many instances, innovative. This places
an obligation on researchers to invest time and resources in science
translation. Engagement that bridges the divide between scientific
and participant communities can address some of these challenges.
Furthermore, evaluation of consent tools is important and the
publication of the evaluation of this video is imminent. Finally,
an interactive online educational platform on HIV cure that is
currently under development will complement this video and allow
patients and potential research participants to raise questions
related to the video‘s content and receive answers. This
compendium of tools to facilitate community engagement will
hopefully prepare future research participants for HIV-related trials
– prevention and cure alike.
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